<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04650295</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00185598</org_study_id>
    <nct_id>NCT04650295</nct_id>
  </id_info>
  <brief_title>Non-Pharmaceutical Intervention for Cirrhotic Cramps Reduction: The NICCles Trial</brief_title>
  <official_title>Non-Pharmaceutical Intervention for Cirrhotic Cramps Reduction: The NICCles Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial is evaluating the feasibility of using a non-pharmaceutical treatment to&#xD;
      improve the symptoms and severity of muscle cramps in patients with cirrhosis.&#xD;
&#xD;
      Eligible participants will be randomized to the treatment arm or control group. The treatment&#xD;
      phase of the study will last 28 days. Information about participants will be collected&#xD;
      including surveys and assessments throughout the study. Please note that only the&#xD;
      participants randomized to experimental intervention group (Household Remedy) will be told&#xD;
      what the treatment is during the study period. At the conclusion of the study (time of the&#xD;
      final follow-up assessments), all participants will be debriefed on the use of concealment in&#xD;
      this study as outlined in the protocol regarding the intervention.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 18, 2021</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in cramp severity after 28-days as measured by the Visual Analog Scale for Cramps</measure>
    <time_frame>28 days</time_frame>
    <description>This is a scale that is numbered from 0 (means no cramps) to 10 (worst cramps imaginable).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of cramp-days per person</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days with cramp severity less than 5 on the Visual Analog Scale for Cramps</measure>
    <time_frame>28 days</time_frame>
    <description>This is a scale that is numbered from 0 (means no cramps) to 10 (worst cramps imaginable).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of cramps during study</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in sleep quality based on the Pittsburgh Sleep Quality Index (PSQI)</measure>
    <time_frame>baseline, 28 days</time_frame>
    <description>This study uses one question from the Pittsburgh Sleep Quality Index (PSQI) in which the participants reply how their sleep quality during the past month has been. Responses include: Very Good (0), Good (1), Fair (2), Bad (3), and Very Bad (4) the higher the score the worse the quality of sleep.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Cirrhosis</condition>
  <condition>Muscle Cramp</condition>
  <condition>Ascites</condition>
  <arm_group>
    <arm_group_label>Household Remedy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Tap Water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Household Remedy</intervention_name>
    <description>If the participant experiences a muscle cramp one tablespoon (one sip) of the household product will be taken. The treatment phase of the study will be for 28 days.</description>
    <arm_group_label>Household Remedy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Tap water</intervention_name>
    <description>If the participant experiences a muscle cramp one tablespoon (one sip) of tap water will be taken. The treatment phase of the study will be for 28 days.</description>
    <arm_group_label>Tap Water</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of cirrhosis (criteria per protocol will be used)&#xD;
&#xD;
          -  History of painful muscle spasms, cramps, or charley horses that come on while resting&#xD;
             (they had to have happened 4 times in the past month and bother the participant)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-English speaking&#xD;
&#xD;
          -  Unable or unwilling to provide consent&#xD;
&#xD;
          -  History of liver transplant&#xD;
&#xD;
          -  History of multiple sclerosis&#xD;
&#xD;
          -  History of cerebral palsy&#xD;
&#xD;
          -  History of stroke with paralysis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elliot Tapper, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jad Baki</last_name>
    <phone>734-232-4182</phone>
    <email>jbaki@med.umich.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elliot Tapper, MD</last_name>
    <phone>734-647-9252</phone>
    <email>etapper@med.umich.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jad Baki</last_name>
      <phone>734-232-4182</phone>
      <email>jbaki@med.umich.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>November 24, 2020</study_first_submitted>
  <study_first_submitted_qc>November 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 2, 2020</study_first_posted>
  <last_update_submitted>January 18, 2021</last_update_submitted>
  <last_update_submitted_qc>January 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Elliot B. Tapper</investigator_full_name>
    <investigator_title>Assistant Professor of Internal Medicine</investigator_title>
  </responsible_party>
  <keyword>Liver disease</keyword>
  <keyword>Nutrition</keyword>
  <keyword>quality of life</keyword>
  <keyword>sleep</keyword>
  <keyword>non-pharmaceutical intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Cramp</mesh_term>
    <mesh_term>Spasm</mesh_term>
    <mesh_term>Ascites</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

